SEROLOGICALS CORP 4
4 · SEROLOGICALS CORP · Filed Dec 20, 2004
Insider Transaction Report
Form 4
OCONNELL DESMOND H JR
Director
Transactions
- Exercise/Conversion
Common Stock, $0.01 par value
2004-12-20$4.81/sh+12,500$60,163→ 74,770.79 total - Conversion
Stock Option
2004-12-20−12,500→ 130,466 totalExercise: $4.81From: 2003-12-31Exp: 2005-11-12→ Common Stock, $0.01 Par Value (12,500 underlying) - Sale
Common Stock, $0.01 par value
2004-12-20$23.00/sh−12,500$287,500→ 62,270.79 total
Footnotes (2)
- [F1]This represents a transaction executed under a stock trading program in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, which permits participating Company executives and Board members to adopt pre-arranged stock trading plans to sell a portion of their Company stock over time.
- [F2]Includes 14,270.79 rights to shares of Common Stock earned as a result of deferring fees earned while serving as a Director of the Company. The shares are issuable upon the last day of service as a Director of the Company.